22.5 C
New York
Wednesday, June 17, 2026

Tag: fluid

Varda Space Industries Launches W-4 with the FAA’s First-Ever Reentry Vehicle Operator License and Debuts an In-House Satellite Bus

The company's fourth mission will focus on demonstrating its new satellite bus, an in-house heatshield, and solution-based pharmaceutical processing. EL SEGUNDO, Calif., June 23,...

IASO Bio presents promising efficacy of Equecabtagene Autoleucel in patients with Multiple Sclerosis in IIT study at the 11th Congress of the European Academy...

SHANGHAI and NANJING, China and SAN FRANCISCO, June 22, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development,...

European Medicines Agency CHMP Recommends EU Approval of Partner Therapeutics IMREPLYS® (sargramostim, rhu GM-CSF) to Treat Exposure to Myelosuppressive Doses of Radiation (Haematopoietic Sub-syndrome...

LEXINGTON, Mass., June 20, 2025 /PRNewswire/ -- Partner Therapeutics, Inc. (PTx) today announced that the Committee for Medicinal Products for Human Use (CHMP) of...

RS and Festo are fueling the evolution of process automation

RS offers an extensive selection of Festo process automation products engineered to improve efficiency, safety, productivity, profitability, and product quality in industrial fluid process...

PureBulk Unveils New Filler-Free Electrolyte Mix for Keto Hydration

ROSEBURG, Ore., June 18, 2025 /PRNewswire/ -- PureBulk, a provider of high-purity, clean supplements, today announced the launch of its new product, Tasty Clear...

Camurus’ POSITANO study shows treatment effects with CAM2029 in polycystic liver disease patients

CAM2029 reduces liver and cyst volume growth compared to placebo Well tolerated with no new or unexpected safety findingsA follow-up Phase 3 study will be...

BioAegis Therapeutics Receives FDA Fast Track Designation for Lead Product, Recombinant Human Gelsolin, for the Treatment of Acute Respiratory Distress Syndrome (ARDS)

Fast Track status enables expedited regulatory review timelines and supports the development of recombinant human plasma gelsolin (rhu-pGSN), a novel immune modulator for inflammatory diseases.

PropertyGrid Revolutionizes Real Estate Investment with Blockchain-Backed Assets, Opening Doors for Investors and Everyday Individuals

TAMPA, Fla., June 17, 2025 /PRNewswire/ -- PropertyGrid, an innovative real estate technology platform, today announced its imminent public launch, poised to fundamentally enhance...

Prospera Energy Announces Operations Update

CALGARY, Alberta, June 17, 2025 (GLOBE NEWSWIRE) -- Prospera Energy Inc. (TSX.V: PEI, OTC: GXRFF) (“Prospera”, “PEI” or the “Corporation”)

ARKO successfully co-hosts the 10th World Summit on Arts and Culture

Cultural and Creative Sectors exploring the way forward in the age of AI and climate crisis and ascertaining its role in society SEOUL, South Korea,...

U.S. Food and Drug Administration Approves CSL’s ANDEMBRY® (garadacimab-gxii), the Only Prophylactic Hereditary Angioedema (HAE) Treatment Targeting Factor XIIa with Once-Monthly Dosing for All...

ANDEMBRY inhibits the top of the HAE cascade by targeting factor XIIa and provides sustained protection from attacksOnce-monthly dosing reduced HAE attacks by a...

Disclosure of trading in own shares

Disclosure of trading in own shares
from 06/09/2025 to 06/13/2025

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsFluid